Progesterone decreases cocaine self-administration in women and in female rats. In a previous study using rats selectively bred for high (HiS) or low (LoS) saccharin intake, HiS rats escalated their cocaine intake compared with LoS rats. Our goal was to examine the effects of progesterone on the escalation of cocaine self-administration in HiS and LoS rats. Four groups of female rats were compared: HiS P (progesterone treated), LoS P, HiS VEH (vehicle treated), and LoS VEH. Rats were trained to self-administer 0.8 mg/kg cocaine intravenously under a fixed-ratio 1 schedule during daily short-access (ShA) 2-h sessions. Rats then self-administered three randomly-presented doses of cocaine (0.2, 0.4, and 1.6 mg/kg), and then had daily 6-h long-access (LgA) sessions with 0.4 mg/kg of cocaine for 21 days. Cocaine intake was then reassessed with the four doses under the ShA condition. Throughout the experiment, rats were treated with daily subcutaneous injections of progesterone (0.5 mg/kg) or an equal volume of vehicle 30 min before each session. During the initial ShA condition, HiS rats earned more cocaine infusions than LoS rats at all doses, and during the subsequent LgA condition, HiS rats escalated cocaine intake, whereas the LoS rats maintained a steady rate. Progesterone treatment potentiated escalation of cocaine intake in the HiS rats but had an opposite effect on LoS rats, attenuating their cocaine self-administration. Results from the post-LgA dose-response ShA condition indicated that both LoS and HiS vehicle-treated and progesterone-treated rats earned more infusions than pre-LgA, but mainly at low doses. These results suggest that genetic differences in drug abuse vulnerability contribute differentially to treatment outcomes during escalation, a critical phase of the drug abuse process.
Introduction
Rats that have been selectively bred for high (HiS) and low (LoS) saccharin intake, and exhibit differential vulnerability in animal models of drug abuse (Carroll et al., 2008) . For example, HiS rats (vs. LoS rats) selfadminister ethanol (Dess et al., 1998) , heroin, and cocaine at increased rates, and show greater cocaine-induced locomotor activity (Carroll et al., 2007a) . As sweet preference is positively related to drug abuse in humans (Janowsky et al., 2003; Wronski et al., 2007) , this animal model of differential vulnerability allows us to investigate genetic factors during key phases of the drug abuse process, such as escalation.
In animal experiments, steadily escalating drug intake during extended periods of long access (LgA) serves as a model of human bingeing. This behavior corresponds to changes in neurobiological reward systems that underlie the transition from intermittent drug use to abuse (Ahmed and Koob, 1998) . Previous work indicates that HiS rats escalate intravenous (i.v.) cocaine self-administration at a faster rate compared with LoS rats (Perry et al., 2006) . Female rats (Roth and Carroll, 2004 ) and monkeys (Carroll et al., 2005) also escalate drug intake more than males, and escalation is a defining factor in the progression toward drug abuse in humans (Fattore et al., 2009) . Preclinical and clinical work indicate that this difference between sexes is largely attributable to the gonadal hormones estrogen and progesterone (Anker and Carroll, 2010a; Carroll and Anker, 2010) , as estrogen enhanced, whereas progesterone inhibited the escalation of cocaine self-administration in female rats . In clinical studies with women, estrogen was associated with increased cocaine-induced positive subjective effects (Sofuoglu et al., 1999; Evans et al., 2002) , whereas pretreatment with progesterone attenuated these responses [Sofuoglu et al., 2001 [Sofuoglu et al., , 2002 [Sofuoglu et al., , 2004 Evans and Foltin, 2006 ; but see Reed et al. (2011) for opposite effects with amphetamine].
Given the possible therapeutic value of progesterone during bingeing phases of drug abuse, the extent to which it may reduce escalation in an animal model of cocaine intake warrants investigation. The purpose of the present study was to compare the effects of systemic progesterone on the escalation of i.v. cocaine self-administration in rats that differ widely in drug abuse vulnerability and motivation to seek drugs of abuse, HiS and LoS rats (Carroll et al., 2008) . In addition, results from previous studies indicated that female rats and monkeys showed greater responsiveness than males to both pharmacological (Carroll et al., 2001; Campbell et al., 2002; Cosgrove and Carroll, 2004; Anker et al., 2009; Anker and Carroll, 2010b) and behavioral (i.e., alternative nondrug reinforcement, such as preferred foods or wheel running/ exercise) (Carroll et al., 2000; Cosgrove et al., 2002; Cosgrove and Carroll, 2003) methods of drug abuse treatment. Thus, based on the sex difference data, it was hypothesized that the more vulnerable HiS rats would show a greater reduction in cocaine intake than LoS rats. Dose-response functions during short-access (ShA) periods were also assessed before and after the LgA condition, as previous work had shown long-term increases in ShA drug intake after LgA (Roth and Carroll, 2004; Larson et al., 2007) .
Methods

Subjects
Thirty-four experimentally-naive adult female rats, selectively bred at the University of Minnesota from Occidental HiS and LoS lines (Occidental College, Los Angeles, California, USA), served as subjects in this study. The HiS and LoS lines were cultivated through breeding pairs based on extreme saccharin phenotype scores as described previously (Carroll et al., 2008) . Phenotype scores were derived from a 24-h twobottle test (Badia-Elder et al., 1996) in which 24-h consumption of a 0.1% saccharin solution was compared with 24-h water intake [saccharin score = ((saccharin mlwater baseline ml) Â 100)/body weight].
Before the experiment, rats were pair-housed in plastic cages with stable humidity, light-dark cycle (12-12 h; lights on at 06:00 h), and temperature, and were allowed ad-libitum access to pellet chow and water. Chronic, indwelling catheters were implanted in the rats' jugular veins using a procedure described by Carroll and Boe (1982) . After recovery, rats were allowed continuous access to water and were given 16 g of ground food at the end of each experimental session. All experimental procedures were approved by the University of Minnesota Institutional Animal Care and Use Committee under Protocol 1008A87754, and they complied with the Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research (National Research Council, 2003) .
Apparatus
Rats were individually housed in 24 custom-made octagonal operant conditioning chambers (Physics Department, University of Minnesota, Minneapolis, Minnesota, USA; Carroll et al., 2001 ) that contained a drinking spout, a recessed food receptacle, two stimulus lights, an active and inactive lever, and a house light. Infusion equipment remained attached to the rats during and following self-administration sessions. During the sessions, the house light was illuminated, and a response on the active lever resulted in the delivery of an i.v. infusion of cocaine and illumination of the lights above the lever for the length of the infusion. Responses on the inactive lever illuminated the stimulus lights above the lever for the duration of an infusion, but did not result in an infusion.
Procedure
Rats were allowed to recover for 3 days after surgery and were then trained to self-administer cocaine (0.8 mg/kg) under a fixed-ratio 1 schedule of reinforcement during 2-h daily sessions. Throughout training and the rest of the experiment, HiS and LoS rats received subcutaneous injections of either progesterone [0.5 mg/kg; HiS P (progesterone treated), n = 9; LoS P, n = 7] or vehicle [peanut oil; HiS VEH (vehicle treated), n = 9; LoS VEH, n = 9] 30 min before each session. Rats were studied for a total of approximately 50 days. The estrous cycle was not controlled in the present experiment, as previous work has shown that cocaine, when self-administered under the LgA conditions of the present study, disrupts the cycle phase .
Once rats acquired stable cocaine self-administration at 0.8 mg/kg of cocaine, they were allowed to self-administer each of the three doses of cocaine that were given in mixed order (0.2, 0.4, and 1.6 mg/kg) for three sessions of stable responding. The session length was then extended to 6 h (LgA; 09:00-15:00 h) for 21 days, and subsequently, cocaine intake was reassessed under the ShA doseresponse condition (0.2, 0.4, 0.8, and 1.6 mg/kg).
Data analysis
Responses and infusions served as the primary dependent measures. Responses and infusions during LgA were averaged into seven blocks of 3 days each and analyzed using three-factor repeated-measures analyses of variance (ANOVAs) with phenotype (LoS vs. HiS) and treatment (progesterone vs. vehicle) as the between-group factors, and day (LgA) as the repeated measure. The number of responses and infusions during the pre-LgA and post-LgA dose-response conditions were analyzed with separate three-factor repeated-measures ANOVAs with phenotype and treatment as the between-subject factors, and dose as the repeated measure. Additional three-factor repeatedmeasures ANOVAs with phenotype as the between-subject factor, and dose and access condition (pre-LgA vs. post-LgA) as repeated measures were conducted. After a significant main effect, post-hoc tests were conducted using Fisher's least significant difference protected t-tests. Statistical analyses were conducted using GB Stat (Dynamic Microsystems Inc., Silver Spring, Maryland, USA).
Results
Pre-long-access dose-response condition
There were no significant effects of treatment (progesterone vs. vehicle) on cocaine-maintained responses or cocaine infusions during the pre-LgA dose-response condition; however, HiS rats had more responses [F(1,135) = 8.43, P < 0.01] (not shown) and infusions [F(1,135) = 8.67, P < 0.01] ( Fig. 1c and d vs. Fig. 1a and b) than LoS rats.
Long access
Similar to the pre-LgA condition, there was no significant effect of progesterone treatment on cocaine-reinforced lever responses during LgA, but Fig. 2a and b show that HiS rats had more responses than LoS rats [F(1,237) = 7.04, P < 0.05] (not shown). For infusions, there was a significant main effect of phenotype [F(1,237) = 24.13, P < 0.01] and a significant treatment Â phenotype Â day interaction [F(6,237) = 2.25, P < 0.05]. A subsequent posthoc analysis indicated that both HiS groups (HiS VEH and HiS P) earned significantly more infusions during their last 3-day block compared with their first 3-day block (P < 0.05) ( Fig. 2a, b, and d) , indicating escalation of cocaine intake. In contrast, LoS rats (LoS VEH and LoS P) did not escalate their drug intake ( Fig. 2a-c) . HiS VEH rats earned more infusions than LoS VEH rats during blocks 4-7 (P < 0.05) ( Fig. 2a ), whereas HiS P rats earned more cocaine infusions than LoS P across all LgA blocks (P < 0.05) (Fig. 2b ). The HiS P group earned more infusions during blocks 2 and 3 than the HiS VEH group (P < 0.05) (Fig. 2d) . In contrast, LoS P rats earned significantly fewer cocaine infusions than LoS rats treated with the vehicle during blocks 2 and 3 (P < 0.05) (Fig. 2c) . (c) HiS VEH; (d) HiS P. # Significant phenotype difference for the respective dose and LgA (pre or post) condition (P < 0.05). *Significant withinsubject difference between pre-LgA versus post-LgA conditions (P < 0.05). HiS P, high saccharin intake (progesterone treated); HiS VEH, high saccharin intake (vehicle treated); LgA, long access; LoS P, low saccharin intake (progesterone treated); LoS VEH, low saccharin intake (vehicle treated). and c), and the LoS P group earned more 0.2mg/kg infusions than the LoS VEH group (P < 0.05) (Fig. 1b) . LoS rats treated with progesterone earned fewer 0.4 mg/kg cocaine infusions than HiS P rats (P < 0.05) ( Fig. 1b and  d) . Comparison of cocaine intake under the dose-response conditions before and after LgA for each group indicated that HiS VEH rats earned more infusions post-LgA compared with pre-LgA [F(1,63) = 6.14, P < 0.05] (Fig. 1c ), and LoS P rats earned more infusions of 0.2 and 0.8 mg/kg cocaine after LgA compared with that before LgA (P < 0.05) (Fig. 1b) .
Saccharin preference test
Results from saccharin testing confirmed saccharin phenotype status and indicated that HiS rats consumed more saccharin than LoS rats. Although HiS groups' scores were higher than LoS groups' scores [F(1,19) = 13.40, P < 0.01], there were no significant differences in saccharin scores (± SEM) as a result of previous progesterone treatment in either LoS or HiS groups (LoS VEH = 5.8 ± 5.7; LoS P = 10.0 ± 1.3; HiS VEH = 22.3 ± 3.2; HiS P = 20.7 ± 3.0).
Discussion
In the present study, we used an animal model to examine genetic influences on receptivity to a pharmacological treatment for cocaine bingeing. The primary finding was that the pharmacological treatment (i.e., progesterone) enhanced cocaine self-administration in the HiS and it decreased cocaine self-administration in the LoS rats under the LgA condition (as is illustrated when comparing Fig. 1a  and b ). Specifically, on days 3-9, progesterone (vs. vehicle) potentiated cocaine self-administration in the HiS rats, whereas it suppressed intake in the LoS rats. The emergence of progesterone's effects on cocaine self-administration was restricted to days 3-9, suggesting that animals may have become tolerant to the effects of progesterone on cocaine during LgA. Altering the dosing regimen such that progesterone was administered every other day may have prolonged its effect on LgA cocaine self-administration. The lack of a treatment effect in HiS rats on days 10-21 may be due to a ceiling effect. For example, HiS rats have a greater capacity to continue to escalate cocaine intake at the end of a 21-day LgA condition (Perry et al., 2006) . In addition, the lack of an effect on days 1-3 may have been the result of the change in session length from 2 to 6 h. Results from several studies indicate that treatment effects and individual differences in LgA cocaine intake often emerge after several days of cocaine self-administration Mantsch et al., 2008; Anker et al., 2011; Gipson et al., 2011) . In contrast to the results in the LgA condition, progesterone enhanced cocaine intake at the lowest cocaine concentration in the LoS rats after the LgA period, thus illustrating a complex interaction between phenotype, treatment, phase, and dose.
Two important factors that need to be considered when comparing results from the present and previous studies are strain and selective breeding. Previous studies demonstrating an attenuating effect of progesterone on cocaine selfadministration have almost exclusively used female Wistar rats, whereas in the present study Sprague-Dawley rats were used (for review see Anker and Carroll, 2010a) . Furthermore, findings indicate that receptivity to drug abuse treatment is strongly influenced by strain. For example, Haile and Kosten (2001) demonstrated that, the effects of several D2 and D1 agonists and antagonists differed between Lewis and Fischer 344 rats, and similar to the findings with progesterone, administration of one treatment (SKF 38393) increased cocaine self-administration in Fischer 344 rats (drug abuse resistant) and decreased it in Lewis rats (drug abuse prone). An additional consideration when comparing the present results to previous findings is that rats in the present study were selectively bred for differential saccharin intake over successive generations. With each generation, the behavioral phenotype (and the underlying genes) between HiS and LoS rats has increasingly diverged. Thus, the fact that progesterone treatment facilitated cocaine self-administration in HiS rats and had an opposite effect in LoS and Wistar rats could be explained by the contribution of genetic influences associated with strain (in the case of outbred Wistar rats) and selective breeding (in the case of LoS rats).
Regardless of treatment status (progesterone or vehicle), HiS rats escalated cocaine self-administration during the LgA condition, whereas LoS rats maintained a lower steady rate of cocaine intake. These findings agree with previous reports indicating that HiS (vs. LoS) rats are more likely to escalate their cocaine intake under similar LgA conditions (Perry et al., 2006; Carroll et al., 2007b) . This confirms that the HiS and LoS rat lines are useful genetic models of drug abuse vulnerability and resistance, respectively (for review see Carroll et al., 2008) . Results from the ShA sessions before and after LgA provide further evidence of greater intake in HiS than LoS rats, particularly at the lower doses of cocaine, as seen previously (Lynch and Carroll, 1999; Carroll et al., 2002; Roth and Carroll, 2004) .
The attenuating effects of progesterone on i.v. cocaine self-administration have been reported by our laboratory under similar LgA conditions and during other phases of drug abuse that are modeled in outbred Wistar female rats Anker and Carroll, 2010a) . Results from clinical work provide crossspecies support to these findings by indicating that progesterone treatment decreased positive subjective ratings of smoked and i.v. cocaine in women (Sofuoglu et al., 2001 (Sofuoglu et al., , 2002 (Sofuoglu et al., , 2004 Evans and Foltin, 2006) . The results of the present study suggest that although progesterone may be efficacious in decreasing responses to cocaine, this treatment effect may depend on the individual's drug abuse vulnerability.
It has been reported that females are more vulnerable to several aspects of drug abuse than males (Carroll and Anker, 2010) , and they respond differentially to treatments for drug abuse (Carroll et al., 2001; Campbell et al., 2002; Cosgrove and Carroll, 2004) . The present results suggest that other individual differences (sweet preference) that predict higher and lower levels of drug abuse, result in different receptivity to treatments (even in opposite ways). These results also suggest that other vulnerability markers expressed in animal models (e.g. impulsivity) should be tested for their reactivity to treatment strategies. Further evidence for genetic contributions in sensitivity to the treatment of the escalation of cocaine self-administration has been presented in a recent study by Holtz and Carroll (2011) . Similar to the results of the present study, baclofen treatment increased the escalation of cocaine self-administration in HiS female rats and decreased it in LoS rats.
The present results highlight the importance of individual differences in susceptibility to treatment for drug abuse. Just as female-specific treatments have been suggested based on sex difference studies (Fattore et al., 2009; Carroll and Anker, 2010) , development of vulnerability-specific treatments may be in order as well. The present model that links genetically mediated markers of drug abuse vulnerability, such as sweet intake, to differential treatment outcomes may also prove useful for the emergent clinical strategy of pharmacogenetics (Haile and Kosten, 2009) , in which genomic variations between individuals govern treatment choices.
